SCHEMBL9873318

SCHEMBL9873318

CC(C)c1nc2c(Oc3ccccc3)nnc(O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PPARG P37231 2/20 0.33
ABCB11 O95342 1/20 0.33
EGFR P00533 1/20 0.33
ERBB2 P04626 1/20 0.33
CYP3A4 P08684 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
CYP2C9 P11712 1/20 0.33
ADRB3 P13945 1/20 0.33
ADRA2B P18089 1/20 0.33
SLC6A2 P23975 1/20 0.33
TBXAS1 P24557 1/20 0.33
HTR2C P28335 1/20 0.33
AGTR1 P30556 1/20 0.33
HTR2B P41595 1/20 0.33
AGTR2 P50052 1/20 0.33
PDE3A Q14432 1/20 0.33
LTB4R2 Q9NPC1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9872232 0.93 AGTR1 (0.33) PPARGABCB11EGFRERBB2CYP3A4
SCHEMBL9873620 0.92 PPARG (0.34) PPARG
SCHEMBL9874542 0.91 AGTR1 (0.32) PPARGABCB11EGFRERBB2CYP3A4
SCHEMBL9873245 0.90 AGTR1 (0.34) PPARGABCB11EGFRERBB2CYP3A4
SCHEMBL9873778 0.90 AGTR1 (0.33) PPARGAGTR1AGTR2
SCHEMBL9873887 0.89 PPARG (0.32) PPARGAGTR1AGTR2
SCHEMBL9874401 0.89 AGTR1 (0.36) PPARGABCB11EGFRERBB2CYP3A4
SCHEMBL9873638 0.89 PPARG (0.33) PPARGABCB11EGFRERBB2CYP3A4
SCHEMBL9873205 0.89 PPARG (0.32) PPARGABCB11EGFRERBB2CYP3A4
SCHEMBL9873729 0.88 AGTR1 (0.36) PPARGABCB11EGFRERBB2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1991019715-A1 1H-SUBSTITUTED-IMIDAZO[4,5-d]PYRIDAZINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-12-26 WO disclosed